HomeLGND • NASDAQ
Ligand Pharmaceuticals Inc
$103.99
Jan 13, 11:54:06 AM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$106.28
Day range
$102.79 - $106.02
Year range
$67.53 - $129.90
Market cap
1.99B USD
Avg Volume
121.42K
P/E ratio
42.85
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
51.81M57.64%
Operating expense
32.73M42.98%
Net income
-7.17M30.19%
Net profit margin
-13.8455.73%
Earnings per share
1.8480.39%
EBITDA
19.95M92.15%
Effective tax rate
-13.14%
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
219.64M15.30%
Total assets
954.87M24.13%
Total liabilities
113.69M12.20%
Total equity
841.18M
Shares outstanding
18.90M
Price to book
2.37
Return on assets
3.01%
Return on capital
3.36%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
-7.17M30.19%
Cash from operations
36.53M377.77%
Cash from investing
-46.51M-138.46%
Cash from financing
55.08M1,584.40%
Net change in cash
45.48M629.64%
Free cash flow
32.53M1,377.31%
About
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further. The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud. In 2018 its CEO was listed among the top five highest paid CEOs in San Diego. Wikipedia
Founded
Sep 1987
Website
Employees
58
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu